CBD-focused biopharmaceutical company Avicanna Inc. AVCN AVCNF 0NN said Friday it has completed a commercial export of CBD Isolate and CBD full spectrum psychoactive cannabis resin to a leading Chilean homeopathic and naturopathic pharmaceutical company through Santa Marta Golden Hemp (SMGH) S.A.S., its Colombian subsidiary.
Designed to supply partner companies and manufacture Avicanna’s own finished products, Cannabis Derivatives - branded as Aureus - are cultivated, extracted and manufactured at a cultivation and extraction infrastructure in Santa Marta, Colombia.
SMGH also supplies other pharmaceutical and cosmetics companies with cannabinoids including CBD, THC, and rare cannabinoids such as CBG, the Toronto-based company confirmed.
This new export to Chile is a recurring order and part of an ongoing relationship with an established homeopathic Chilean company.
Recent news from Avicanna:
- Avicanna Raises $3.2M Via Non-Brokered Offering, Announces Warrant Repricing
- Avicanna Ships Its Feminized Cannabis Seeds To Peru And Argentina
- Avicanna Files Patent For New Cannabinoid-Based Epilepsy Medication
- Avicanna Completes Registration And Commercial Export Of Pura Earth CBD Brand In Ecuador
- Avicanna Reaches Brazil With Aureus Branded Full Spectrum Psychoactive CBD Cannabis Extracts
Photo: Courtesy of Kindel Media
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.